Two new appointments at Eisai
This article was originally published in Scrip
Executive Summary
Eisai (US) has named Steven Sembler senior vice-president of oncology and institutional care and Dr Ann Miller senior vice-president of the primary care and speciality business unit. Mr Sembler joins from Roche, where he most recently served as vice-president of speciality care, commercial operations, where he oversaw Roche's oncology, virology, HIV and anti-infectives business units. Dr Miller was previously in commercialisation and marketing consulting. She has more than 20 years' experience in the biopharmaceutical industry, having formerly worked Merck & Co and Amgen.